Sequential versus concomitant non-bismuth quadruple therapy as first-line eradication for helicobacter pylori

被引：0
|
作者：
Pereira, F. [1 ]
Azevedo, R. [1 ]
Linhares, M. [1 ]
Ramos, D. [1 ]
Pinto, J. [1 ]
Caldeira, A. [1 ]
Tristan, J. [1 ]
Pereira, E. [1 ]
Sousa, R. [1 ]
Banhudo, A. [1 ]
机构：
[1] Hosp Amato Lusitano, Castelo Branco, Portugal
来源：
NEUROGASTROENTEROLOGY AND MOTILITY | 2019年 / 31卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
208
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Bismuth containing quadruple and concomitant therapy for 2 weeks are effective for the first-line Helicobacter pylori eradication: A prospective randomized trial
    Woo, H.
    Chung, J.
    Kim, S.
    Kim, J.
    Kwon, K.
    Kim, K.
    Kim, Y.
    Park, D.
    HELICOBACTER, 2017, 22
  • [22] Quadruple therapy with moxifloxacin and bismuth for first-line treatment of Helicobacter pylori
    Ciccaglione, Antonio Francesco
    Cellini, Luigina
    Grossi, Laurino
    Marzio, Leonardo
    WORLD JOURNAL OF GASTROENTEROLOGY, 2012, 18 (32) : 4386 - 4390
  • [23] A randomized clinical trial comparing triple therapy versus non-bismuth based quadruple therapy for the eradication of Helicobacter Pylori in Kuwait
    Alfadhli, Ahmad
    Alboraie, Mohamed
    Afifi, Mostafa
    Dangi, Abhijit
    JOURNAL OF GLOBAL INFECTIOUS DISEASES, 2022, 14 (03) : 99 - +
  • [24] EFFICACY OF CONCOMITANT NONBITHMUTH-BASED QUADRUPLE THERAPY AS FIRST-LINE TREATMENT FOR ERADICATION OF HELICOBACTER PYLORI
    Moon, B.
    Lim, H.
    Lee, S.
    Han, K.
    Chung, J.
    Lee, Y.
    HELICOBACTER, 2011, 16 : 131 - 132
  • [25] HELICOBACTER PYLORI ERADICATION RATES WITH 10-DAY NON-BISMUTH QUADRUPLE THERAPY AND 10-DAY SEQUENTIAL THERAPY IN KOREA
    Kim, S. Y.
    Lee, J.
    Chung, S. Y.
    Jung, S. W.
    Park, J. J.
    Chun, H. J.
    Lee, S. W.
    HELICOBACTER, 2014, 19 : 131 - 131
  • [26] Comparing the Efficacy among Concomitant, Sequential, and Tailored Therapy as the First-Line Therapy for Helicobacter pylori Eradication
    Kim, Jin Il
    Cheung, Dae Young
    Kim, Jae J.
    Lee, Sang Woo
    GASTROENTEROLOGY, 2016, 150 (04) : S876 - S876
  • [27] Sequential versus Standard Triple Therapy for First-Line Helicobacter pylori Eradication: An Update
    Nyssen, Olga P.
    Martinez, Belen
    Megraud, Francis
    Savarino, Vincenzo
    Fallone, Carlo A.
    Bazzoli, Franco
    Gisbert, Javier P.
    ANTIBIOTICS-BASEL, 2024, 13 (02):
  • [28] Ensuring the highest eradication rates in H. pylori: the case of non-bismuth quadruple concomitant therapy
    McNicholl, Adrian G.
    Pena, A. Salvador
    Gisbert, Javier P.
    EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2016, 33 : 1 - 2
  • [29] BISMUTH QUADRUPLE THERAPY VERSUS CONCOMITANT THERAPY FOR THE FIRST-LINE TREATMENT OF HELICOBACTER PYLORI INFECTION: SYSTEMATIC REVIEW AND META-ANALYSIS
    Dajti, E.
    Cominardi, A.
    Frazzoni, L.
    Fuccio, L.
    Eusebi, L. H.
    Vestito, A.
    Lisotti, A.
    Galloro, G.
    Romano, M.
    Bazzoli, F.
    Zagari, R. M.
    DIGESTIVE AND LIVER DISEASE, 2023, 55 : S173 - S174
  • [30] Eradication Rates for Esomeprazole and Lansoprazole-Based 7-Day Non-Bismuth Concomitant Quadruple Therapy for First-Line Anti-Helicobacter pylori Treatment in Real World Clinical Practice
    Hung, Kuo-Tung
    Yang, Shih-Cheng
    Wu, Cheng-Kun
    Wang, Hsing-Ming
    Yao, Chih-Chien
    Liang, Chih-Ming
    Tai, Wei-Chen
    Wu, Keng-Liang
    Kuo, Yuan-Hung
    Lee, Chen-Hsiang
    Chuah, Seng-Kee
    INFECTION AND DRUG RESISTANCE, 2021, 14 : 1239 - 1246
12345